GEP100/BRAG2 (an ARF6 GEF) expression is higher in invasive breast carcinoma, and its recruitment to EGFR in breast cancer cells results in ARF6 activation and stimulation of cell invasion [53]. Here, EGFR is linked to breast cancer.